Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials.

导出 LinkOut

翻译打印收藏纠错

第一作者： Faraidoon,Haghdoost

第一单位： The George Institute for Global Health, University of New South Wales, Sydney, Australia.

作者： Faraidoon,Haghdoost ^[1] ; Francesca,Puledda ^[2] ; David,Garcia-Azorin ^[3] ; Eva-Maria,Huessler ^[4] ; Roberta,Messina ^[5] ; Patricia,Pozo-Rosich ^[6]

作者单位： The George Institute for Global Health, University of New South Wales, Sydney, Australia. ^[1] Headache Group, Wolfson CARD, SLaM Biomedical Research Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, National Institute for Health Research-Wellcome Trust King's Clinical Research Facility, King's College Hospital, London, United Kingdom. ^[2] Headache Unit, Department of Neurology, Hospital Clínico Universitario de Valladolid, Gerencia Regional de Salud de Castilla y Leon, Valladolid, Spain. ^[3] Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, Germany. ^[4] Neuroimaging Research Unit and Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy. ^[5] Headache Unit and Headache and Neurological Pain Research Group, Neurology Department, Hospital Universitari Vall d'Hebron and VHIR, Barcelona, Spain. ^[6]

关键词 CGRP gepants meta-analysis migraine prevention randomised controlled trial

主题词人类(Humans);降钙素基因相关肽(Calcitonin Gene-Related Peptide);偏头痛(Migraine Disorders);头痛(Headache);随机对照试验(主题)(Randomized Controlled Trials as Topic)

DOI 10.1177/03331024231159366

PMID 36855951

发布时间 2024-06-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交